In March 2026, NHS England hit a milestone that hadn't been reached in over four years: 65.3% of patients waiting 18 weeks or less for elective treatment. NHS Chief Executive Sir Jim Mackey called it "a huge moment." Health Secretary Wes Streeting said it was "the biggest cut in waiting lists in a single month in 17 years." And on one level, both are right — the improvement is genuinely meaningful and took real effort from NHS staff operating under sustained pressure.
On another level, a system where 34.7% of patients are still waiting more than 18 weeks for routine hospital treatment, where the total waiting list stands at over 7.2 million cases, and where cancer waiting time targets are significantly below the standard that's supposed to be met — that's a system that has made progress from a very difficult position but has a long way still to go.
Both things are true simultaneously. Here's what UK patients actually need to know.
The Headline Numbers: What March 2026 Actually Shows
The referral-to-treatment (RTT) data for March 2026, published by NHS England in May, shows:
The waiting list fell to approximately 7.1 million incomplete pathways — down from a record 7.7 million in September 2023 and down by over 312,000 from the same point the previous year. That year-on-year reduction of 312,000 is described as the largest in 16 years.
18-week performance reached 65.3% — the national interim target of 65% was met nationally for the first time since November 2021. This means approaching 450,000 fewer people were waiting over 18 weeks for NHS treatment in March compared to July 2024.
Long waits: the number of patients waiting more than a year for treatment has dropped by almost half (48%) in the last 12 months, and by over 69% (208,000) from the start of July 2024. The percentage of waits longer than 52 weeks has fallen to its lowest level since June 2020.
By April 2026 (the most recent monthly data at the time of writing), the overall waiting list increased slightly to 7.22 million cases, with approximately 2.53 million patients waiting over 18 weeks. About 100,000 patients have been waiting over a year — an increase from 94,000 the previous month. So the March improvement has not been fully sustained in April, which the Health Foundation notes may reflect that the March numbers were partly driven by "sprint efforts" — additional evening and weekend clinics that aren't maintainable at that pace indefinitely.
The median waiting time for patients waiting to start treatment is currently 11.9 weeks — significantly above the pre-COVID median wait of 7.2 weeks in April 2019. Even with the improvements made in the past year, patients are still waiting considerably longer than they were before the pandemic.
What the 65% Target Actually Means — and What It Doesn't
The 65% interim target for March 2026 was one of five targets NHS England set as milestones toward the government's ultimate goal: 92% of patients waiting 18 weeks or less for elective care by 2029. That 92% standard — the NHS constitutional standard — has not been met for over a decade.
Meeting 65% nationally is progress. But there are important caveats.
Geographically, there is substantial inequality underneath the national number. The percentage of waits within 18 weeks ranged from 53% to 74% across different integrated care boards — meaning some areas of the country are at or near target, while others are still performing at significantly below-standard levels. Meeting the national target doesn't mean patients everywhere are getting equally improved access.
And just over 4 in 10 acute NHS trusts did not achieve the required improvements to hit the 65% level, despite the national headline being met. Those trusts will require additional targeted support in the coming year.
The Health Foundation's analysis suggests that sustaining the improvement rate seen in the months leading up to March will be difficult without continued investment. "Recent gains may reflect short-term measures that will be difficult to maintain over the long term," the Foundation notes. Whether April's slight reversal represents a temporary blip or a signal of a sustainability problem will become clearer over the summer months.
Where Progress Has Been Strongest
Some regional trusts have achieved genuinely impressive results. In the East of England, the overall waiting list fell from around 947,000 to 895,000 over the year — a reduction of close to 52,000 patients. The Princess Alexandra Hospital NHS Trust moved from 46.2% of patients treated within 18 weeks in March 2025 to 64.1% by March 2026 — an improvement of nearly 18 percentage points over twelve months.
At West Suffolk NHS Foundation Trust, the proportion of patients receiving diagnostic tests within 6 weeks improved from around 40% to 86%, helping to dramatically reduce downstream treatment waiting times. Digital tools — including a patient portal and patient validation system — allowed clearer communication with patients about their wait times and status, reducing the number of patients who are technically on the waiting list but may not realise their appointment has changed or been rescheduled.
Shropshire's SaTH NHS Trust achieved 68.9% of patients within 18 weeks by March 2026, exceeding the national target, while being named the most improved acute trust in the country over the last year.
These examples matter because they demonstrate what's achievable when the right combination of operational focus, diagnostic investment, and digital tools are applied consistently. The challenge is replicating that across all 200+ NHS trusts.
Cancer Waiting Times: The Area That's Fallen Short
The cancer targets are the part of the March 2026 performance data that is hardest to read positively. And since cancer care involves some of the highest-stakes waits in the NHS, it matters more than the elective waiting list story in terms of direct patient outcomes.
62-day cancer referral-to-treatment target: NHS England set a target of 75% performance against the 62-day target by March 2026. In March 2026, 72.8% of patients began treatment within 62 days of an urgent referral — below the 75% target and significantly below the operational standard of 85%. In April 2026, performance dropped back to 70%.
This means roughly 30% of patients urgently referred with suspected cancer are not starting treatment within the 62-day window the NHS has set for this purpose. The pre-pandemic standard was 85%, and the current 70% performance against what is now a broader measurement (covering 43% more patients than before) is a concerning picture.
The government's 10-Year Health Plan and NHS modernisation efforts are aimed at eventually improving this, but cancer waiting time improvement has been slower and more resistant to intervention than the elective care waiting list numbers.
A&E Waiting Times: The Perennial Pressure
The emergency care picture in 2026 remains under severe pressure.
In May 2026, 75.7% of people attending A&E were admitted, transferred, or discharged within four hours — below the NHS operational target of 78%. The NHS had not met the four-hour A&E target consistently since before the pandemic. In April 2026, the number of patients waiting over 12 hours for an emergency admission increased to approximately 50,000 — up from 48,000 the previous month. This is about 121 times higher than the same figure in May 2019.
That number — 121 times higher — captures the scale of how dramatically emergency care has changed. Patients who would have been admitted to a ward within hours in 2019 are now frequently waiting on trolleys in A&E corridors for many hours, sometimes overnight, waiting for a bed to become available.
The A&E pressures are partly a symptom of problems elsewhere in the system — delayed discharges keeping beds occupied by patients who are medically ready to leave but have nowhere to go, underfunding of social care meaning hospital beds are blocked, and chronic workforce shortages meaning staffing ratios on wards can't safely accelerate turnover.
Ambulance response times have improved from their worst recent levels but remain outside targets. Category 2 response times (for conditions like suspected heart attacks and strokes, where the 18-minute target has never been consistently met in recent years) averaged 27 minutes and 21 seconds in April 2026 — the fastest performance since May 2021, but still well above the 18-minute standard.
What Labour's Plan Is — and Where It Stands
The Labour government, in office since July 2024, made reducing NHS waiting times its top healthcare priority. The approach has several components that are now being implemented in parallel:
More use of the independent sector. NHS England has contracted with private hospitals and clinics to handle elective procedures, generating additional throughput capacity without requiring new NHS capital investment. This is politically contentious in some parts of the Labour coalition, but the practical effect on waiting list reduction is real.
Expansion of community diagnostic centres (CDCs). By September 2025, over £2.2 billion of capital spending had been drawn down to create CDCs — freestanding diagnostic facilities where patients can get MRI scans, blood tests, and other investigations without going through a hospital outpatient department. The goal is to diagnose faster and route patients to treatment more efficiently.
Surgical hubs. Facilities focused specifically on high-volume, low-complexity operations — knee and hip replacements, cataracts, tonsillectomies — where consistent operating conditions can produce higher throughput than general hospital theatres, which are subject to cancellation pressures from emergency demand.
The NHS Modernisation Bill. Announced in 2026, this represents another significant structural reorganisation of NHS governance — the NHS has now been through multiple major reorganisations over the past fifteen years. The Health Foundation and others have flagged that the time and management capacity consumed by reorganisation inevitably comes at the cost of frontline improvement work.
The 2029 target — 92% of patients within 18 weeks — is the government's flagship NHS commitment. The OBR and independent health think tanks describe it as very ambitious. Starting from 65% and needing to reach 92% within five years while managing the cancer backlog, A&E pressures, and workforce constraints simultaneously is genuinely difficult.
Whether it's achievable depends on investment, workforce expansion, and whether the structural reforms actually improve rather than disrupt the system's functioning. The honest answer from independent health analysts is: the direction is right, the pace will have to accelerate, and the 2029 target may slip if the April reversal persists.
What This Means Practically for Patients
If you're on an NHS waiting list right now, here's what the data translates into for you:
Check your wait category. Some conditions are being prioritised more aggressively than others. Cancer urgent referrals get (or should get) the 62-day pathway. Elective procedures vary enormously by speciality and region. Find out which category you're in.
Use the NHS App to track your referral. The NHS App now shows referral status, and digital patient portals at many trusts allow you to see where you are in a queue. Some trusts have reported patients who were waiting for operations not realising they'd been moved forward — or that their GP referral hadn't been received. Proactively checking your status saves wasted time.
Consider whether private treatment is viable for specific needs. For certain procedures, private costs have fallen to levels that are accessible to a wider range of people, particularly for straightforward orthopaedic procedures (knee replacements, shoulder issues) where NHS waits can still run 12–18 months in some areas. It's worth getting a quote before assuming it's unaffordable.
GP access has improved. NHS staff numbers have increased, with doctor numbers up 24% and nurses up 22% over the five years to February 2026. The vacancy rate fell to 6.7% in December 2025. This is translating into slightly improved GP access in many parts of England, though with significant geographic variation.
The NHS in 2026 is a system making genuine progress from a position of genuine difficulty. The March milestone is real and deserves acknowledgment. The gap between where the service is and where it needs to be is also real and doesn't benefit from obscuring.